Immomab SA
Immomab reported total assets of 49,746 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Immomab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +33 % Total assets +35 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immomab's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 24 May 2022
Immomab's financial analysis
Management and control of Immomab
Immomab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0468.300.657
- VAT number
- BE0468300657
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 15 Dec 1999
- Registered office
- 6220 Fleurus
- Latest accounts
- 2025 · filed on 24 Jun 2026
Immomab (SA) has been based in Fleurus since 1999, active in: —. For 2025, it reports a net profit of 4,848 € and equity of 49,036 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Immomab
Companies in the same business, of comparable size and area, outside its group.
- Smoelwerk Buying and selling of own real estate Ghent · balance sheet 49,748 €
- Ann Bogaerts Nursing and midwifery activities Bornem · balance sheet 49,749 €
- TPS Wholesale of agricultural machinery, equipment and supplies Nazareth-De Pinte · balance sheet 49,759 €
- Sanocare Retail sale of medical and orthopaedic goods Hamont-Achel · balance sheet 49,760 €
- Berbéris Invest Rental and operating of own or leased real estate Braine-l'Alleud · balance sheet 49,728 €
- LIC International Manufacture of pharmaceutical preparations Ranst · balance sheet 49,768 €
- Unifis Non-specialised wholesale trade Ghent · balance sheet 49,720 €
Frequently asked questions about Immomab
What is the revenue of Immomab?
Immomab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Immomab?
In Belgium, the VAT number is the company number prefixed with BE: BE0468300657 for Immomab, if the company is VAT-registered. Its company number (CBE) is 0468.300.657.
Where is the registered office of Immomab?
According to the CBE register, the registered office of Immomab is in 6220 Fleurus.
What is the equity of Immomab?
At the close of the 2025 financial year, the equity of Immomab amounts to 49,036 €, a solvency of 98.6% of total assets.
Who manages Immomab?
The register lists 2 active mandates at Immomab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immomab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →